Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
8.99
+0.06 (0.67%)
At close: Jun 27, 2025, 4:00 PM
9.09
+0.10 (1.11%)
After-hours: Jun 27, 2025, 7:35 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $120.18 million as of June 27, 2025. Its market cap has decreased by -37.00% in one year.
Market Cap
120.18M
Enterprise Value
117.43M
1-Year Change
-37.00%
Ranking
Category
Stock Price
$8.99
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $120.18M, an increase of 74.97%. That is a compound annual growth rate of 12.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 119.38M | -19.13% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |